Estimate Recalculated Sep 9, 2024 12:20AM EST
Barbara Klencke does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., eFFECTOR Therapeutics, Inc., TScan Therapeutics, Inc., and Xencor Inc.
Barbara Klencke's CIK is 0001647647
2024 was Barbara Klencke's most active year for acquiring shares with 7 total transactions. Barbara Klencke's most active month to acquire stocks was the month of May. 2022 was Barbara Klencke's most active year for disposing of shares, totalling 11 transactions. Barbara Klencke's most active month to dispose stocks was the month of June. 2020 saw Barbara Klencke paying a total of $72,709.60 for 173,041 shares, this is the most they've acquired in one year. In 2022 Barbara Klencke cashed out on 342,551 shares for a total of $550,000.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!